CML promoted the migration of SMCs (Figure 6(a)) and stimulated the secretion of IL-1β, IL-6, and TNF-α inflammatory factors (Figure 6(b)). This evidence concerns the gene IL6 and chronic myelogenous leukemia, BCR-ABL1 positive.